Claims extracted
16
sentences that state something as happening or true
Uncertain
0%
0 of 16 hedged
("reportedly", "may", "according to")
Leaning
not political
takes no side on a contested political question
Publisher signals
59/100
The Independent's corrections and
hedging, across everything collected from it. Not a measure of accuracy.
Outlets on this story
1
Health
Same framing elsewhere
1
articles that frame the event the way this one does
A large clinical trial combining Moderna's mRNA cancer vaccine with Merck's immunotherapy reduced the risk of melanoma death or recurrence by 42%, the companies announced on Thursday, potentially opening a new era in personalized oncology.
Moderna shares closed more than 17% lower on Thursday after the trial findings leaked on an oncology website, despite having nearly quadrupled through Wednesday's close since August when the trial's success was first announced without full data. Merck stock also fell about 1.8%.
asserted
stock → combine → data
The Phase 3 trial, which tracked more than 1,100 patients, also revealed that the combination treatment reduced the risk of the cancer spreading by 38%.
asserted
treatment → track → %
The findings mark the first data demonstrating that pairing a custom vaccine based on a patient's unique tumor mutations with a drug that boosts the immune system can successfully halt the disease.
asserted
that → mark → disease
The vaccine was tested alongside Merck's Keytruda, one of the world's top-selling medicines.
asserted
vaccine → test → medicines
Keytruda functions by removing a natural brake that cancer cells rely on to hide from immune attack.
asserted
cells → function → attack
Meanwhile, the vaccine instructs patient cells to produce copies of specific mutations, allowing the immune system to seek out and destroy them.
asserted
system → instruct → them
Moderna CEO Stephane Bancel stated that the findings herald a new chapter in treating cancer.
asserted
findings → state → cancer
"With this ability to create new T cells that are specific to your tumor... the clinical impact is very profound, and as we saw in the Phase 2 (trial), very lasting," Bancel said in an interview.
asserted
Bancel → create → interview
The companies are preparing to file for US regulatory approval, expecting to launch the personalized cancer vaccine in 2027, Bancel noted.
asserted
Bancel → prepare → 2027
The results, evaluating patient outcomes over the initial two years following treatment, are scheduled for presentation on Saturday at the European Society for Medical Oncology conference in Madrid.
asserted
results → evaluate → Madrid
Among subjects who received the vaccine paired with Keytruda, 82.2% remained cancer-free after two years, compared to 70% of those who received Keytruda alone.
asserted
who → receive → Keytruda
It is not by chance," said Dr. Hussein Tawbi, a melanoma expert and trial investigator at the University of Texas MD Anderson Cancer Center.
asserted
Tawbi → say → Center
Ahead of the meeting, several Wall Street analysts noted that investors were looking for the combination to cut the risk of recurrence by 40% or more.
asserted
combination → note → %
"There appears to be a sell-on-the-news reaction playing out here," William Blair analyst Myles Minter wrote in a research note, pointing out that Moderna shares remained up 525% this year even with Thursday's downward move.
asserted
shares → appear → move
Minter added that the findings were "great data, in our view, but investors will continue to debate the fundamental valuation.
asserted
investors → add → valuation
"
The trial assessed nine doses of the vaccine, known as intismeran, administered with Keytruda beginning 13 weeks after surgery to remove melanoma lesions, comparing responses against the standard single-therapy treatment of Keytruda alone.
asserted
trial → assess → Keytruda
The Aporia
